logo
Plus   Neg
Share
Email

Ford Q2 U.S. Sales Down 33.3%

Ford Motor Co. (F) said Thursday that its total sales for the second-quarter declined 33.3 percent, hurt by the ongoing global COVID-19 pandemic.

The company's retail was down much less than industry at 14.3 percent, the company said in a statement.

Ford's U.S. sales for the second-quarter declined 33.3 percent to 433,869 vehicles from 650,336 vehicles last year.

Car sales for the quarter dropped 59.5 percent year-over-year to 44,650 units from 110,195 units, while truck sales also decreased 26.6 percent to 237,891 units and SUVs sales declined 29.9 percent to 151,328 units as compared to a year earlier.

U.S. vehicle sales for major companies fell sharply in the second-quarter.

On Wednesday, General Motors said that it delivered 492,489 vehicles in the second quarter of 2020, a decrease of about 34 percent from last year, reflecting Covid-19 pandemic's effect on demand and tight inventories.

Nissan Group reported that total U.S. sales for the second-quarter were 177,328 units, a decrease of 49.5 percent from the prior year.

Meanwhile, Volkswagen of America reported that its second-quarter total sales dropped 29 percent to 69,933 vehicles from 98,736 vehicles in the prior year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT